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ABSTRACT 
 
Diagnosing cardiovascular system (CVS) diseases from clinically measured data is 
difficult, due to the complexity of the hemodynamic and autonomic nervous system 
(ANS) interactions. Physiological models could describe these interactions to enable 
simulation of a variety of diseases, and could be combined with parameter estimation 
algorithms to help clinicians diagnose CVS dysfunctions. This paper presents 
modifications to an existing CVS model to include a minimal physiological model of 
ANS activation. A minimal model is used so as to minimise the number of parameters 
required to specify ANS activation, enabling the effects of each parameter on 
hemodynamics to be easily understood. The combined CVS and ANS model is verified 
by simulating a variety of CVS diseases, and comparing simulation results with common 
physiological understanding of ANS function and the characteristic hemodynamics seen 
in these diseases. The model of ANS activation is required to simulate hemodynamic 
effects such as increased cardiac output in septic shock, elevated pulmonary artery 
pressure in left ventricular infarction, and elevated filling pressures in pericardial 
tamponade. This is the first known example of a minimal CVS model that includes a 
generic model of ANS activation and is shown to simulate diseases from throughout the 
CVS. 
 
Keywords: Hemodynamics, modelling, autonomic nervous system, cardiovascular 
system 
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1 Introduction 
 
Diagnosing cardiovascular system (CVS) diseases requires medical staff to interpret a 
range of clinical data and measurements of patient CVS function. Measurements seen by 
the clinician such as pressures (eg. mean arterial, pulmonary artery, central venous), 
volumes (eg. ventricle volumes measured by echocardiography) and cardiac output (CO) 
can be influenced by a variety of hydraulic effects, underlying diseases, autonomic 
nervous system (ANS) responses, and the interactions between these mechanisms. This 
confusing array of effects makes the process of diagnosing CVS diseases difficult. 
 
Physiological models could be built that describe these interactions and enable simulation 
of a variety of diseases. These models could then be fitted to clinical data for specific 
patients by adjusting model parameters using parameter estimation algorithms [1]. The 
resulting model parameters may then provide useful insight into the underlying disorder 
and assist the clinician in selecting a suitable treatment strategy. Such models need to be 
simple enough such that their parameters can be identified given the available clinical 
data, whilst retaining enough complexity to capture the fundamental dynamics. 
 
There are many examples of physiological models in the literature that simulate the 
hemodynamics of the heart and circulatory system to varying degrees of complexity 
[2,3,4,5,6,7]. However, most are only shown to simulate specific types of dysfunctions in 
certain areas of the CVS, and very few include consideration of ANS function [8,9]. 
Those that do simulate ANS function focus on specific diseases, and whilst showing the 
usefulness of the modelling approach, have not been shown to be able to simulate the 
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necessary range of CVS diseases seen in clinical practice [8,9]. Detailed models of the 
circulatory system including short and long term regulatory function have been created, 
such as that proposed by Guyton et al. [10], however the complexity of these models 
limits their potential applicability for patient specific simulations [11]. 
 
This research investigates modifications to a previously presented model of CVS function 
to include a model of ANS response [6,7]. The aim is to develop a model of the CVS 
including ANS response which can simulate a variety of relevant disease scenarios 
commonly seen in critically ill patients, including examples of the 4 fundamental types of 
shock. Whilst no formal identifiability analysis will be performed in this paper, the 
models presented here are formulated so as to have minimal complexity. This is intended 
to both enable understanding of the individual contributions of the model parameters to 
the overall hemodynamics, and increase the possibility of identifying model parameters 
from clinical data.  
 
This paper will present an overview of the CVS model and a description of the ANS 
model. The CVS model and the combined CVS and ANS model are used to investigate 
the effects of the individual mechanisms of ANS response on arterial blood pressure and 
cardiac output, and to simulate a variety of different diseases. In each case the simulated 
results are examined to see if the model can reproduce common physiological 
understanding and clinical observations.  
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2 Model specification 
2.1 Cardiovascular system model 
The minimal CVS model used in this study is shown schematically in Figure 1 including 
the governing equations. The model structure and method of implementation is outlined 
in detail in Smith et al. [6], and is summarised only briefly here. The two central heart 
chambers represent the left and right ventricles (lv and rv). Resistances at the inlet and 
exit of the right ventricle simulate pressure drops of blood flow entering through the 
tricuspid valve (Rtc) and exiting through the pulmonary valve (Rpv). For the left ventricle, 
resistances affect blood flow entering through the mitral valve (Rmt) and exiting through 
the aortic valve (Rav). Ventricular interaction due to the septum (spt) and pericardium 
(peri) is also accounted for in the model. The effects of the thoracic cavity (Ppl) pressure 
on the ventricles and pulmonary circulation chambers are also included to account for the 
influence of respiration. 
 
The systemic circulation is made up of two chambers representing the pressures (P) and 
volumes (V) in the vena-cava (vc) and the aorta (ao) connected by a resistor to simulate 
the systemic resistance (Rsys). Similarly, the pulmonary circulation is simulated as the 
pulmonary artery (pa) connected to the pulmonary vein (pu) by the pulmonary vascular 
resistance (Rpul). Both ventricles are driven by time varying elastances which cycle 
between a maximum defined by the end-systolic pressure-volume relationship (ESPVR), 
and a minimum end-diastolic pressure-volume relationship (EDPVR). This enables 
simulation of pulsatile blood flow which results in ventricular pressures varying between 
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systolic and diastolic values. A cardiac driver function (Equation C4 in Figure 1) is 
defined that controls the variation in ventricular elastance between diastolic and systolic 
levels over the cardiac cycle for a specified heart rate (HR). Figure 2 illustrates the 
ESPVR and EDPVR on a pressure-volume (PV) diagram of the cardiac cycle. The 
contractility (Ees) of the left ventricle wall (lvf), right ventricle wall (rvf) and septum (spt) 
are adjusted by using the parameters Ees,lvf, Ees,rvf and Ees,spt respectively. Similarly, the 
ventricular end-diastolic elastances (P0) are adjusted by varying the parameters P0,lvf, P0,rvf 
and P0,spt, the non-linearity in this elastance (λ) being adjusted using the parameters λlvf, 
λrvf and  λspt.  
 
This model contains 6 state variables representing the compartmental volumes (Vpa, Vpu, 
Vlv, Vao Vvc and Vrv), and uses 38 parameters in the governing equations shown in Figure 
1. Reference values for these parameters can be found in numerous literature sources and 
are listed in Tables 1 and 2 [4,6,8,9]. Simulations performed using the model have been 
previously shown to reproduce normal values and characteristic trends in volumes and 
pressures in the heart and circulatory system that are comparable to a normal human 
[6,7]. The model is designed to contain a minimal number of parameters in order to 
improve identifiably, whilst preserving parameters that are necessary to simulate a variety 
of relevant diseases, as will be illustrated.  
2.2 Autonomic nervous system activation model 
Changes in arterial blood pressure are detected through baroreceptors located in the walls 
of the large systemic arteries, and transmitted to the central nervous system. A drop in 
arterial blood pressure causes simultaneous stimulation of the sympathetic nervous 
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system and inhibition of the parasympathetic vagal activity. The primary effects of this 
autonomic nervous system response are: constriction of the arterioles which increases 
peripheral resistance; constriction of the venous system which pushes more blood into the 
circulation; and improved cardiac function through increased heart rate and contractility. 
These changes occur rapidly, where typically the ANS is capable of activating these 
compensatory mechanisms and causing large change in blood pressure within 5-40 
seconds [12]. 
 
The model of ANS activation presented here includes all of the four, above mentioned, 
mechanisms for autonomic regulation, i.e.: vaso-constriction; venous constriction; 
increased heart rate and increased ventricular contractility [8]. ANS activation is assumed 
to respond to changes in systemic arterial blood pressure (∆Pao), the effects of which are 
modelled as proportional changes in the following CVS parameters: systemic resistance 
(Rsys); venous dead-space (Vd,vc); heart rate (HR) and ventricular contractilities (Ees,lvf and 
Ees,rvf) [12,13]. This section describes the mathematical model formulation of these 
relationships along with their physiological justification and estimation of the model’s 
parameter values.  
 
Equations 1-5 describe the relationship between changes in Pao and the resulting changes 
in the selected CVS model parameters. The ANS parameters (SRsys, SVdvc, SHR and SEes) 
define the sensitivity of the CVS parameters to changes in Pao, where Rsys(100), Vd,vc(100), 
HR(100), Ees,lvf(100) and Ees,rvf(100) define the values of the CVS parameters when Pao is 
100mmHg.  
 8
∆Rsys = SRsys ⋅ ∆Pao ⋅ Rsys(100)                                                          (1) 
∆Vd,vc = SVdvc ⋅ ∆Pao ⋅ Vd,vc(100)                                                         (2) 
∆HR = SHR  ⋅ ∆Pao ⋅ HR(100)                                                           (3) 
∆Ees,lvf = SEes ⋅ ∆Pao ⋅ Ees,lvf(100)                                                        (4) 
∆Ees,rvf = SEes ⋅ ∆Pao ⋅ Ees,rvf(100)                                                        (5) 
This linear model can be seen as a very simple representation of the ANS. However, it 
will be shown that even a simple representation such as this can be used to simulate the 
major characteristics of clinical diseases. The relationships described in Equations 1-5 
will now be discussed individually, in order to provide physiological justification of the 
relationships in terms of major ANS responses (i.e. vaso-constriction, venous 
constriction, heart rate and contractility) and to provide estimation of the sensitivity 
parameters listed in Table 3. 
 
Vaso-constriction responds to a decrease in Pao by constricting the arterioles to increase 
Rsys, the resulting feedback acting so as to reduce the changes in Pao. This mechanism is 
simulated in the ANS model by increasing Rsys on changes in Pao (Equation 1). Using the 
systemic resistance sensitivity (SRsys) listed in Table 3, means that the vaso-constriction 
response to a drop in average Pao from 100mmHg to 80mmHg will be to increase Rsys by 
35%.  
 
Venous constriction responds to changes in Pao by increasing the elastance of the larger 
peripheral blood vessels, which contain most of the blood volume in the body. This 
constriction increases the stressed blood volume [8,12,14]. The total blood volume (Vtot) 
 9
in the model is made up of the sum of the stressed blood volume and the unstressed blood 
volume, where the unstressed blood volume is equal to the sum of all the dead-space 
volumes (e.g., Vd,vc, Vd,ao, Vd,pa and Vd,pu) [9]. Venous constriction is simulated by 
reducing the venous dead-space in the model (Vd,vc), on changes in Pao (Equation 2), 
which has the effect of pushing blood from the unstressed blood volume into the stressed 
blood volume. Using the venous dead-space sensitivity (SVdvc) listed in Table 3, means 
that the venous-constriction response to a drop in average Pao from 100mmHg to 
80mmHg will be to decrease Vd,vc by 35% from the base value.  
 
The pumping ability of the heart responds to changes in Pao by increasing heart rate and 
contractility [8,14]. These mechanisms are simulated in the ANS model by increasing 
HR, Ees,lvf and Ees,rvf on changes in Pao (Equations 3-5). Using the heart rate sensitivity 
(SHR) and contractility sensitivity (SEes) values listed in Table 3, means that a drop in 
average Pao from 100mmHg to 80mmHg results in increased HR by 50% and increased 
left and right ventricular contractilities (Ees,lvf and Ees,rvf) by 35% respectively. 
3 Simulation results 
3.1 Using the model to simulate autonomic nervous system 
activation 
This section investigates whether changes in the CVS parameters selected to represent 
ANS function, reasonably represent the physiological changes seen due to the ANS. 
Simulations are performed using the CVS model to investigate the independent effects of 
changes in CVS parameter values (Rsys, Vd,vc, HR, Ees,lvf and Ees,rvf) on average arterial 
blood pressure (Avg Pao) and cardiac output (CO). Each of the CVS parameters is varied 
independently over a range from 0.1 to 2 times their base values, shown in Tables 1 and 
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2. Values of other parameters are held constant and the model is run to a steady state 
solution to find Avg Pao and CO. In this way the independent effects of each ANS 
response on blood pressure and cardiac output are found. 
 
Figure 3 shows the results of these simulations. Several important conclusions can be 
drawn from these in relation to common physiological and clinical understanding, 
illustrating the power of these simple models to capture well known changes in 
hemodynamics. The simulated effect of changes in venous dead space (Vd,vc) are 
nonlinearly related to Pao and CO, meaning that at low values of Vd,vc, Pao and CO are 
only changed minimally. Reducing dead-space can be seen as equivalent to increasing 
blood volume. Therefore, this simulation is consistent with the clinical observation that 
while increases in blood volume in hypovolemic patients will cause increases in blood 
pressure and CO, these values tend to remain stable when blood volume is increased in 
adequately volume loaded patients [12]. The effect of changes in both contractility (Ees) 
and heart rate (HR) on Pao and CO are also non-linear, where Pao and CO are 
significantly affected at low values of Ees and HR, but to a lesser degree at high values. 
This flattening of the Pao and CO curves as Ees and HR are increased is indicative of the 
increasing dependence of the heart on ventricular preload [12]. Systemic vascular 
resistance (Rsys) is almost linearly related to average Pao and CO, where an increase in 
Rsys causes an increase in blood pressure and a decrease in cardiac output. This response 
is consistent with the clinically observed response to vaso-constrictor treatment [12]. 
3.2 Using the model to simulate CVS diseases 
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This section investigates the use of the combined CVS and ANS model to simulate the 
effect of severe acute cardiovascular diseases on hemodynamic variables. Five different 
cases of severe acute cardiovascular diseases are simulated, representing dysfunctions 
commonly seen in the intensive care unit, i.e.: hypovolemic shock; cardiogenic shock; 
septic shock; pericardial tamponade and pulmonary embolism. Each disease is simulated 
by adjusting model parameters from the base values given in Tables 1 and 2. In each case 
the model is run to steady state conditions. The resulting simulated CVS hemodynamics 
are compared with trends reported in medical literature.  
 
In order to investigate the effects of the model of ANS activation on hemodynamics, 
simulation results are given for each disease using the CVS model only (Table 4, values 
in brackets) and using the combined CVS and ANS model (Table 4, values without 
brackets). The variables shown in Table 4 are selected to characterise the hemodynamic 
response, i.e.: The average pressures in the peripheral chambers (Pao, Pvc, Ppa and Ppu) 
which give the filling pressures and the afterload of each ventricle; The cardiac output 
(CO), showing how effectively the heart and circulatory system are working together to 
transport blood; The end-diastolic left and right ventricular volumes (LVEDV and 
RVEDV), indicating the preload in each ventricle, which is dependent on the venous 
return [12]; The average deflection of the septum (Vspt) and the average pressure in the 
pericardium (Pperi), quantifying the level of ventricular interaction.  
 
To enable comparison between model simulations, the severity of the diseases simulated 
in all cases except pulmonary embolism are adjusted so that the average Pao will reduce to 
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80mmHg when ANS activation is included. Moderate pulmonary embolism typically 
does not cause such a large drop in blood pressure, so in this case the severity of illness is 
modified until Pao is reduced to 98 mmHg, resulting in a proportionally smaller ANS 
activation. Simulation of each of the disease states is now considered in turn. 
3.2.1 Hypovolemic shock 
Hypovolemic shock is caused by a severe drop in total blood volume, due to dehydration, 
hemorrhage or other fluid loss. Reduced blood volume is clinically characterised by a 
drop in ventricular filling pressures, cardiac output and mean arterial pressure [13,14]. 
Hypovolemic shock is simulated using the model by reducing total blood volume (Vtot) 
by 3.1 litres. This example simulates a patient with acute hypovolemic shock due to 
external hemorrhage. 
 
Simulations without ANS activation (Table 4) result in significant decreases in all 
hemodynamic pressures to levels inadequate to maintain life, and no steady state solution 
was reached. In simulations using the combined CVS and ANS model, Table 4 shows 
that ANS activation partially compensates for the drop in arterial blood pressure due to 
the blood loss by activating mechanisms to increase blood pressure. These compensatory 
mechanisms cause simulated pressures and flows to stabilise at values that are adequate 
to maintain life. Average Pao stabilises at 80mmHg, but all pressures are low relative to 
base values along with end-diastolic ventricular volumes and cardiac output. The model 
response described matches commonly seen trends during hypovolemic shock [14].  
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3.2.2 Septic shock 
Septic shock is a common type of distributive shock that is often characterised by a drop 
in systemic vascular resistance and venous elastance [15,16]. This dilation in the systemic 
circulatory system is thought to occur due to a drop in vascular auto-regulatory control 
[14]. Acute septic shock prior to fluid resuscitation is usually clinically characterised by a 
drop in blood pressures throughout the circulatory system, particularly in the aorta (Pao) 
whilst cardiac output increases markedly [17]. Septic shock is simulated using the model 
by reducing systemic resistance (Rsys) by 50% and increasing venous dead-space by 1.7 
litres. This example simulates a patient suffering from acute septic shock, perhaps as a 
result of a bacterial infection. Values of SRsys and SVdvc were not changed in this 
simulation, in order to maintain consistency with the other disease simulations, although 
these values could also be affected in septic shock due to impaired auto-regulatory 
function. 
 
Simulations without ANS activation (Table 4) result in values of hemodynamic pressures 
and cardiac output below those necessary to maintain life. In simulations with the 
combined CVS and ANS model, Table 4 shows that the pressure drops are much less 
significant, with Avg Pao stabilising at 80 mmHg and pulmonary artery pressure (Ppa) 
almost recovering to its base value. The left and right ventricular volumes also decrease, 
but the cardiac output increases from a normal value of 5.6l/min to 6.8l/min. The 
characteristic rise in cardiac output commonly seen in septic shock is only present in 
simulations that include ANS activation.  
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3.2.3 Cardiogenic shock 
Cardiogenic shock is often caused when the heart is unable to pump enough blood to 
maintain adequate perfusion of oxygen to the tissues including the myocardium [14,18]. 
The lack of oxygen supply to the myocardium causes even further depression of cardiac 
function by decreasing the ventricular contractility and increasing diastolic elastance [19]. 
Cardiogenic shock is characterised hemodynamically by decreased mean arterial pressure 
below 90mmHg, decreased cardiac output, hypotension and an elevated pulmonary 
capillary occlusion pressure to greater than 15 mmHg [14,18,19,20]. Cardiogenic shock is 
simulated using the model by reducing the left ventricular contractility (Ees,lvf) by 28%, 
and increasing diastolic elastance (Po,lvf) by 350%. This example simulates a patient 
suffering from left ventricular infarction due to a blocked coronary artery where the left 
ventricular function is severely compromised due to ischemia. The value of SEes,lvf was 
not altered for these simulations, although the ability of the heart to increase contractility 
due to ANS activation could also be impaired in cardiac shock. 
 
Simulations without ANS activation (Table 4) result in significant reductions in systemic 
circulatory pressures (Pao and Pvc) and CO, while Ppa reduces slightly and Ppu increases. In 
simulations with the combined CVS and ANS model, Table 4 shows that the systemic 
pressures and CO reduce to a lesser degree, Ppa increases significantly above the base 
value, and Ppu is increased to a greater degree. These increased pulmonary pressures are 
the main contributing factor to pulmonary edema commonly seen in patients with left 
ventricular dysfunction [14]. The results show that Ppu increases even without ANS 
activation, and is most likely caused by the increase in left ventricular end-diastolic 
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elastance which increases the filling pressure necessary for the left ventricle to continue 
pumping. The increase in Ppa after the inclusion of ANS activation is probably 
predominantly caused by the decrease in venous dead-space, as discussed by Burkhoff 
and Tyberg [8].  
3.2.4 Pericardial tamponade 
Pericardial tamponade is caused by an excessive build-up of fluid in the pericardium 
which limits the expansion of the ventricles. It can occur due to a variety of causes 
including trauma resulting from injury, or complications as a result of surgery [14]. In the 
long term the pericardium can slowly stretch, but in the acute stages the pericardium can 
have a high stiffness causing significant pericardial pressure increases [14]. In most 
cases, pericardial tamponade will cause a rise in filling pressures along with a reduction 
in cardiac output and mean arterial pressure [14,21]. Pericardial tamponade is simulated 
using the model be reducing the pericardium dead-space volume (Vo,pcd) by 194 ml, to 
achieve steady state Pao of 80 mmHg. This example simulates a patient following cardiac 
surgery where fluid has rapidly built up in the pericardium. 
 
Simulations without ANS activation (Table 4) result in significantly reduced after-load 
pressures (Pao and Ppa), while filling pressures (Pvc and Ppu) remain relatively constant. In 
simulations using the combined CVS and ANS model, Table 4 shows that the arterial 
pressures reduce to a lesser degree, and filling pressures increase. The simulations show 
that the commonly seen increase in filling pressures is only simulated with inclusion of 
the ANS model. The pressure in the pericardium (Pperi) increases considerably in both 
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simulations due to the stretching the pericardium, and this in turn causes the reduction in 
ventricular preload volumes below half the base values.  
3.2.5 Pulmonary embolism 
Pulmonary embolism occurs due to blockage of a large fraction of the pulmonary 
circulation [22,23]. Diagnosis can be difficult, with patients appearing to be 
hemodynamically stable, with normal mean arterial pressure and cardiac output [14,23]. 
However, the pressure in the pulmonary artery pressure (Ppa) can rise to 40mmHg, 
increasing right ventricular after-load and causing significant right ventricular dilation. In 
previously healthy patients, more than 50% of the pulmonary vasculature must be 
obstructed before pulmonary artery pressures will increase significantly [14]. Pulmonary 
embolism is simulated using the model by increasing pulmonary vascular resistance 
(Rpul) by 240%.  
 
Simulations without ANS activation (Table 4) result in increases in right heart preload 
and afterload pressures (Pvc and Ppa), while left heart preload and after-load pressures (Ppu 
and Pao) reduce. In simulations with the combined CVS and ANS model, Table 4 shows 
that the same trends are seen with a greater increase in Pvc and Ppa, and a lesser decrease 
in Ppu and Pao. The simulation shows the typical clinical picture of apparent hemodynamic 
stability (Pao = 98 mmHg and CO = 5.2 l/min), but with an elevated pulmonary artery 
pressure (Ppa = 32.3 mmHg). The simulated increased right ventricular after-load causes 
the right ventricle to expand, compressing the left ventricle. This effect is simulated in the 
reduced value of left ventricular volume and the average septal deflection, which 
becomes negative (Vspt = -0.7 ml) compared to the base value of 4.6 ml. A positive value 
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for Vspt means the septum is deflecting into the right ventricle as normal, but a negative 
value means the septum is deflecting into the left ventricle. This interaction occurs even 
without ANS activation and is caused by the increased Rpul, causing a damming of blood 
in the right heart. 
4 Discussion and Conclusions 
This study has shown how a minimal CVS model can be modified to include the effects 
of ANS activation in order to simulate a variety of different CVS diseases. Four main 
ANS mechanisms have been identified that respond to blood pressure changes. The effect 
of each of these mechanisms on simulated hemodynamics is first investigated separately, 
before combining them in the model to simulate their combined effects in disease states. 
This is the first known example of a minimal CVS model that includes a generic model of 
ANS activation that is verified by simulating hemodynamic trends reported in medical 
literature for a variety of CVS diseases.  
 
The necessity for the ANS model is illustrated in this paper through physiologically 
realistic disease conditions which can only be simulated using the combined CVS and 
ANS model. ANS activation is required to simulate pressure changes in hypovolemic and 
septic shock, without which simulated hemodynamic pressure levels are inadequate to 
maintain life. ANS activation is required to simulate the characteristic rise in CO during 
septic shock and the increased pulmonary artery pressure during cardiogenic shock due to 
left ventricular infarction. In pericardial tamponade, ANS activation is required to 
simulate the increased filling pressures and in pulmonary embolism ANS activation is 
also required to simulate the typical clinical picture of apparent hemodynamic stability 
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with significantly increased pulmonary artery pressure. In addition to these effects, the 
model captures ventricular interaction during pulmonary embolism. It is possible that the 
model could also be used to simulate impairments in ANS function such as in 
cardiovascular autonomic neuropathy [24]. 
 
The ANS model presented here uses only linear equations relating changes in CVS 
parameters to changes in arterial pressure, meaning that only 4 additional parameters are 
necessary, these representing ANS sensitivity. The same combined CVS and simple ANS 
model was used for all disease simulations. Despite the simplicity of the ANS model, it is 
possible to simulate the characteristic hemodynamic responses of CVS diseases seen in 
clinical practice.  
 
All the simulated diseases are in their acute stage, which means that only the rapid reflex 
responses are simulated. It is assumed that slower acting mechanisms such as renal fluid 
retention do not affect hemodynamics significantly during the acute stage, or over short 
periods of time.  
 
Simulation of the range of diseases shown here is the first step in verifying the model for 
use as a tool for aiding the clinician in diagnosing CVS diseases. Previous publications 
have presented identifiability analysis of the CVS model, excluding the ANS [25]. No 
formal analysis of the identifiability of the combined CVS and ANS model has been 
presented here, however, the simplicity of the linear equations included in the ANS 
model mean that only 4 additional parameters are necessary. Future work is required to 
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develop parameter identification methods, such as those described by Hann et al. [1], to 
enable patient specific diagnosis for the combined CVS and ANS model. If shown to be 
identifiable, then studies are required to investigate whether the model parameters fitted 
from individual patient data accurately reflect the disease state of that patient. For 
example, if the model is fitted to data from a patient with left ventricular myocardial 
infarction, will the fitted parameters show a reduction in left ventricular contractility? In 
this way the model could be used as decision support to identify CVS disease states in 
critically ill patients. 
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Figure 1, SmithAndreassen - CMPB-D-06-00222 
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Figure 2, SmithAndreassen - CMPB-D-06-00222 
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Figure 3, SmithAndreassen - CMPB-D-06-00222 
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Table 1, SmithAndreassen - CMPB-D-06-00222 
Parameter Ees Vd Vo λ Po 
Units kPa/l l l 1/l kPa 
Left ventricle free wall (lvf) 454 0.005 0.005 15 0.17 
Right ventricle free wall (rvf) 87 0.005 0.005 15 0.16 
Septum free wall (spt) 6500 0.002 0.002 435 0.148 
Pericardium (pcd) - - 0.2 30 0.0667 
Vena-cava (vc)  1.5 2.83 - - - 
Pulmonary artery (pa) 45 0.16 - - - 
Pulmonary vein (pu) 0.8 0.2 - - - 
Aorta (ao) 94 0.8 - - - 
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Table 2, SmithAndreassen - CMPB-D-06-00222 
Parameter Value 
Mitral Valve (Rmt)  0.06 kPa.s/l 
Aortic Valve (Rav)  1.4 kPa.s/l 
Tricuspid Valve (Rtc)  0.18 kPa.s/l 
Pulmonary Valve (Rpv) 0.48 kPa.s/l 
Pulmonary Circulation (Rpul) 19 kPa.s/l 
Systemic Circulation (Rsys) 140 kPa.s/l 
Heart Rate (HR)  80 bpm 
Total blood volume (Vtot) 5.5 l 
Thoracic cavity pressure (Ppl) -4 mmHg 
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Table 3, SmithAndreassen - CMPB-D-06-00222 
Parameter Value  
SRsys -0.0175 mmHg-1 (-0.131 kPa-1) 
SVdvc 0.0175 mmHg-1 (0.131 kPa-1) 
SHR -0.025 mmHg-1 (-0.188 kPa-1) 
SEes -0.0175 mmHg-1 (-0.131 kPa-1) 
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 Table 4, SmithAndreassen - CMPB-D-06-00222 
 Base Hypovol Septic LV Infarct Peri Tamp Pul Emb 
Ventricular filling pressures 
Avg Pvc (mmHg) (2) 2 (NA) -2.7 (-3.6) -0.6 (-2.2) -1.9 (2.0) 4.6 (2.6) 2.9 
Avg Ppu (mmHg) (2) 2 (NA) -2.3 (-3.6) -0.7 (5.3) 10.6 (3.2) 7.4 (1.4) 1.7 
Ventricular afterload pressures 
Avg Pao (mmHg) (100) 100 (NA) 80 (5) 80 (37) 80 (36) 80 (89) 98 
Avg Ppa (mmHg) (16.5) 16.5 (NA) 6.3 (-1.2) 16.0 (11) 19.2 (8.2) 15.4 (30.2) 32.3
Perfusion 
CO (l/min) (5.6) 5.6 (NA) 3.5 (0.9) 6.8 (2.2) 3.4 (1.9) 3.2 (4.9) 5.2 
Ventricular preload volumes 
LVEDV (ml) (115) 115 (NA) 58 (22) 86 (87) 110 (45) 55 (101) 104 
RVEDV (ml) (115) 115 (NA) 46 (21) 88 (58) 61 (47) 52 (128) 130 
Ventricular interaction 
Avg Vspt (ml) (4.6) 4.6 (NA) 4.2 (2.3) 4.5 (4.7) 5.6 (2.8) 3.8 (0.5) -0.7 
Avg Pperi (mmHg) (-3.6) -3.6 (NA) -4 (-4) -4 (-4) -4 (3.7) 4.2 (0.4) -1.3 
 
